This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stocks making big moves yesterday: Planet Labs, Rivian, FOX, Centrus Energy, and IMAX

StockStory - Wed Jun 17, 8:00AM CDT
PL

PL Cover Image

Check out the companies making headlines yesterday:

Planet Labs (NYSE:PL): Earth imaging satellite company Planet Labs (NYSE:PL) fell by 8.2% on Tuesday after the much-hyped Initial Public Offering (IPO) of competitor SpaceX likely prompted investors to reallocate funds. See our full article here.

Is now the time to buy Planet Labs? Access our full analysis report here, it’s free.

Rivian (NASDAQ:RIVN): Electric vehicle manufacturer Rivian (NASDAQ:RIVN) fell by 4.1% on Tuesday after the company laid off hundreds of employees in a push to reduce costs and become profitable. See our full article here.

Is now the time to buy Rivian? Access our full analysis report here, it’s free.

FOX (NASDAQ:FOXA): Cable news and media network Fox (NASDAQ:FOXA) fell by 5.3% on Tuesday after the company's stock continued to fall following its announcement of a $22 billion deal to acquire streaming platform Roku. See our full article here.

Is now the time to buy FOX? Access our full analysis report here, it’s free.

Centrus Energy (NYSE:LEU): Nuclear fuel supplier Centrus Energy (NYSE:LEU) fell by 4.2% on Tuesday after UBS lowered its price target on the stock to $170 from $195, citing higher expected operating costs. See our full article here.

Is now the time to buy Centrus Energy? Access our full analysis report here, it’s free.

IMAX (NYSE:IMAX): Premium cinema technology company IMAX (NYSE:IMAX) rose by 4.7% on Tuesday after strong box office results for the opening of Universal's film 'Disclosure Day,' saw a significant contribution from the company's premium screens. See our full article here.

Is now the time to buy IMAX? Access our full analysis report here, it’s free.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.